MorningStar Laboratories, LLC., (“MSL” or “the Company”), is a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce its expansion in the Midwest with ...

SmartVascular Dx™ Test: Enhancing Vascular Care in the Midwest Provided by GlobeNewswire Jun 25, 2025, 3:00:00 AM ...

Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...

SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide Provided by GlobeNewswire Jun 11, 2025, 11:21:05 AM ...

“Today marks a significant advancement in how we approach vascular and inflammatory health,” said Lawrence Dentice, President, Chief Commercial Officer & Director, MorningStar Laboratories. “The ...

Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...

Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s vascular ...

MorningStar Laboratories, LLC ('MSL” or 'the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its SmartVascular Dx™ (SVDx) test ...

The City of Regina is seeing an early season surge of Dutch elm disease (DED). City officials have confirmed 17 cases so far ...